Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma

Figure 3

Survivals in ENKL with chemotherapy followed by radiotherapy categorized by the prognostic index. Overall survival (A) and Progression-free survival (B) of patients received chemotherapy followed by radiotherapy (n=102) categorized by the absolute monocyte and lymphocyte prognostic index. Group 1 (low risk), AMC <0.50×109/L and ALC>1.10×109/L; Group 2 (intermediate risk), AMC ≥ 0.50×109/L or ALC ≤ 1.10×109/L; Group 3 (high risk), AMC ≥ 0.50×109/L and ALC ≤ 1.10×109/L.

Back to article page
\